Amir Weiss - 03 Mar 2023 Form 4/A - Amendment Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Chief Accounting Officer
Signature
/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss
Issuer symbol
TEVA
Transactions as of
03 Mar 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Aug 2023, 16:14:06 UTC
Date Of Original Report
07 Mar 2023
Previous filing
02 Mar 2023
Next filing
07 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TEVA Ordinary Shares 30,183 03 Mar 2023 Direct F1
holding TEVA Ordinary Shares 40,859 03 Mar 2023 Direct F1
holding TEVA Ordinary Shares 44,423 03 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 On March 7, 2023, the reporting person filed a Form 4 which inadvertently reported that, following vesting of certain restricted share units, he owned fewer of the Issuer's Ordinary Shares than he owns. As reported in this amendment, following the three transactions previously reported, he owned 44,423.41 Ordinary Shares.